Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trinity Biotech PLC

0.6600
-0.0379-5.43%
Post-market: 0.67990.0199+3.02%18:25 EDT
Volume:60.17K
Turnover:40.43K
Market Cap:18.16M
PE:-0.29
High:0.6980
Open:0.6616
Low:0.6600
Close:0.6979
Loading ...

Trinity Biotech Plc: Qtrly Diluted Loss per Ads $0.46

THOMSON REUTERS
·
15 Nov 2024

Trinity Biotech Announces Q3 2024 Financial Results

THOMSON REUTERS
·
15 Nov 2024

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
14 Nov 2024

Trinity Biotech to Announce Q3 2024 Financial Results

GlobeNewswire
·
14 Nov 2024

European Equities Traded in the US as American Depositary Move Higher in Monday Trading

MT Newswires Live
·
12 Nov 2024

BRIEF-Trinity Biotech Regains Compliance With Nasdaq Listing Requirements

Reuters
·
07 Nov 2024

Trinity Biotech Regains Compliance With Nasdaq Listing Requirements

THOMSON REUTERS
·
07 Nov 2024

European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday

MT Newswires Live
·
01 Nov 2024

European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading

MT Newswires Live
·
31 Oct 2024

Trinity Biotech Acquires EpiCapture to Enter Oncology Market

TIPRANKS
·
26 Oct 2024

Trinity Biotech Invests in Rapid Sepsis Testing Innovation

TIPRANKS
·
26 Oct 2024

BRIEF-Trinity Biotech Enters Oncology Space With Acquisition Of Prostate Cancer Focused Epicapture

Reuters
·
25 Oct 2024

BRIEF-Trinity Biotech Announces Strategic Investment In Novus Diagnostics To Advance Rapid Sepsis Testing Platform

Reuters
·
25 Oct 2024

Trinity Biotech Buys Prostate Cancer Testing Firm EpiCapture

MT Newswires Live
·
25 Oct 2024

Trinity Biotech acquires 12.5% stake in Novus Diagnostics valued at $2.5M

TIPRANKS
·
25 Oct 2024

Trinity Biotech acquires EpiCapture for initial $3M consideration

TIPRANKS
·
25 Oct 2024